Is Aave Aptos a Good Investment?

BValue
B-Risk

Aave's brand and governance provide dominant moat, but $7M TVL and Move-rewrite risk cap near-term value accrual despite a clean 20-month track record.

|Lending
TVL$2M
FDV$2.0B
TVL/FDV0.00x
Risk GradeB-
Value GradeB

Value Accrual: Does the Aave Aptos Token Capture Value?

Aave Aptos scores B on Hindenrank's value accrual framework (68/100), indicating solid value fundamentals with room for improvement in one or two dimensions. Fee capture scores 17/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is rated 18/25 (reasonably decentralized with some concentration risk), and emission sustainability sits at 18/25. The competitive moat dimension scores 15/25.

Scored as: Business
Fee Capture
17/25
Token Distribution
18/25
Emission Sustainability
18/25
Competitive Moat
15/25

Protocol Health: Is Aave Aptos Still Growing?

Aave Aptos's vitality risk score is 5/10 on Hindenrank's rubric (lower is healthier). This suggests moderate health — Aave Aptos is maintaining activity but may be showing signs of plateauing growth or reduced developer engagement. The protocol is functional but may not be accelerating.

GitHub: aave

Risk-Adjusted View: Is the Upside Worth the Risk?

Risk-Adjusted Position

Blue Chip
High Value
Medium Value
Low Value
High Risk
High Risk Play
Risky
Avoid
Medium Risk
Promising
Neutral
Weak
Low Risk
Aave Aptos
Safe but Stale
Dead Money
See all Blue Chip protocols →

Aave Aptos lands in the Blue Chip quadrant — combining strong value accrual (B) with low risk (B-). This is the most favorable risk-adjusted position, suggesting the protocol delivers real economic value without excessive risk. Protocols in this quadrant are typically suitable as core portfolio holdings.

Risk Context

Aave Aptos carries a risk grade of B- (29/100), classified as moderate risk — some novel mechanisms, generally well-understood. While no critical-severity interactions were identified, 1 high-severity interaction warrant attention. The primary risk factor is: Complete Move-language rewrite of Aave V3.3 introduces new smart contract surface area untested at scale — bugs in Move-specific logic could differ from the battle-tested Solidity version.

Read our full safety analysis →

Where Aave Aptos Sits Among Lending Peers

On risk, Aave Aptos ranks #14 of 95 Lending protocols (top quartile — safer than most). That's 8 points safer than the sector average of 37/100.

The closest peer by risk profile is Benqi (grade B-, 29/100). See the side-by-side comparison to weigh their tradeoffs.

Should you buy Aave Aptos?

Aave Aptos scores B on Hindenrank's value accrual framework, placing it among the above-average Lending protocols. Fee capture scores 17/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is reasonably decentralized with some concentration risk, and emission sustainability sits at 18/25. On the risk side, Aave Aptos carries a B- grade (29/100), which is moderate risk — some novel mechanisms, generally well-understood. The combined risk-value position places Aave Aptos in the Blue Chip quadrant.

Aave Aptos investment outlook for 2026

With $2M in total value locked and FDV of $2.0B, giving a TVL/FDV ratio of 0.00, Aave Aptos's fundamentals support the current valuation from a usage perspective. The competitive moat dimension scores 15/25, suggesting meaningful but not impregnable competitive advantages.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.

This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology

Weekly Commentary

Pro

Week of April 30, 2026

Aave Aptos has completed 20 months of clean operation on the Aptos mainnet, with no exploits or vulnerabilities in the Move-language codebase during that period. TVL has stabilized near $7M — a substantial decline from the September 2024 peak of ~$38M — and growth prospects remain tied to broader Aptos ecosystem adoption. Active governance discussion to raise supply caps for sUSDe, USDC, and USDT signals continued Aave Labs investment in the deployment. The track record improvement from <1 year to >1.5 years warranted a minor grade uplift to B; the Immunefi bug bounty exclusion for Aptos remains the single largest standing risk differentiator versus Aave's EVM deployments.

Related Lending Investment Analyses

Related Lending Safety Analyses

Get risk alerts before it's too late

Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.

Investment analysis uses Hindenrank's value accrual framework across four dimensions: fee capture, token distribution, emission sustainability, and competitive moat. Higher score = better value accrual. Combined with our eight-dimension risk rubric for risk-adjusted positioning. This is not financial advice.